Marcie A. Goldstein
Lawyers
Filters
Dova Pharmaceuticals Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $80 million public offering of common stock of Dova Pharmaceuticals, Inc. The common stock is listed on the NASDAQ…
Solid Biosciences Inc. Initial Public Offering
Davis Polk advised the joint book-running managers in connection with the $133.7 million initial public offering of common stock of Solid Biosciences Inc. The common stock is listed on the…
ConforMIS, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering of 13,333,333 shares of common stock of ConforMis,…
Gates Industrial Corporation plc $731.5 Million Initial Public Offering
Davis Polk advised the representatives of the underwriters in connection with Gates Industrial Corporation plc’s initial public offering of 38,500,000 ordinary shares, at $19.00 per share,…
PagSeguro Digital $2.6 billion IPO
Davis Polk advised the global coordinators and bookrunners in connection with the initial public offering by PagSeguro Digital Ltd. and Universo Online S.A., as selling shareholder, of an…
BeiGene, Ltd. $800 Million Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in the $800 million public offering by BeiGene, Ltd. of American depositary shares. The ADSs are…
Inspired Entertainment Secondary Offering
Davis Polk advised the underwriter in connection with the $35.8 million SEC-registered secondary offering of 4,500,000 shares of common stock of Inspired Entertainment, Inc. by certain…
iClick Interactive Asia Group Limited Initial Public Offering
Davis Polk advised the representative of the underwriters on the initial public offering by iClick Interactive Asia Group Limited of 3,750,000 American Depositary Shares, each two…
Denali Therapeutics Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 15,972,221 shares of common stock of Denali Therapeutics Inc., including shares sold pursuant to the…
Editas Medicine, Inc. $50 Million Follow-On Offering
Davis Polk advised the sole book-running manager in connection with the $50 million follow-on offering of 1,970,000 shares of common stock of Editas Medicine, Inc. The common…